Notably, a modified Gegen Qinlian decoction has been reported to effectively regulate gut microbiota, improve BAs metabolism, and activate the TGR5/cAMP/PKA signaling pathway, thereby exerting therapeutic benefits in mouse models of T2DM (171). Here, GPBAR1 is linked to type 2 diabetes mellitus.